1. Catalogs
  2. WELLS BIO
  3. careSTART™ G6PD Biosensor Analyzer_Eng

careSTART™ G6PD Biosensor Analyzer_Eng

careSTART™ G6PD Biosensor Analyzer_Eng

careSTART™ G6PD Biosensor Analyzer_Eng

Product catalog summary
Overview of G6PD Deficiency: G6PD deficiency is a genetic disorder characterized by low or absent G6PD enzyme activity. Individuals with this condition should avoid certain drugs, such as primaquine and other oxidative stress-inducing medications, to prevent severe side effects like acute hemolysis. Many countries are now including G6PD screening in newborn screening programs.
Product Specifications: The careSTARTTM G6PD Biosensor Analyzer requires no pretreatment or manual steps and uses a small 7uL whole blood specimen. It provides results within 4 minutes and is designed to minimize user error. The device can store up to 1,000 results and features auto-calibration for temperature, enhancing workflow efficiency with rapid and reliable results.
Manufacturer and Distributor Information: The product is manufactured by WELLS BIO, INC. in Seoul, Korea, and distributed by ACCESS BIO, INC. in Somerset, USA.
Order Information: The product line includes the careSTARTTM G6PD Biosensor Analyzer, Biosensor Strips, and Control Levels I and II, with specific catalog numbers and package sizes provided.
Test Procedure: The test involves pressing the power button, inserting the code chip, and using a lancet for specimen collection. The specimen is then injected, and results are displayed.
Performance and Technology: The G6PD correlation analysis from a Haiti study showed a correlation of 0.943 between the careSTARTTM G6PD and Trinity G6PD with a 60% cut-off. The technology uses electrochemical sensing with amperometric measurement.
See more

Catalog excerpts

careSTART™ G6PD Biosensor Analyzer_Eng-1

G6PD deficiency is a genetic disorder, resulting in no or low G6PD activity. People with G6PD deficiency should not take primaquine, an antimalarial drug, and other drugs with high oxidative stress such as ascorbic acid and antimicrobial agents because it could cause serious side effects such as acute hemolysis. Now, more countries are implementing G6PD screening as a part of their newborn screening program. Increase workflow efficiency with rapid and reliable results • No requirement for pretreatment or manual step • 7uL tiny whole blood specimen (Capillary available) • Short turnaround time within 4 minutes • Optimal design to prevent user error • Possible to save 1,000 results 16, Magokjungang 8-ro 1-gil, Gangseo-gu, Seoul, 07795, Republic of Korea +82-2-3660-6900 www.wellsbio.net 65 Clyde Rd. Suite A, Somerset, NJ 08873, USA +1-732-873-4040 www.acce

 Open the catalog to page 1
careSTART™ G6PD Biosensor Analyzer_Eng-2

Performance Enzyme activity detection through Electrochemical sensing technology Amperometric Measurement G6PD Correlation Analysis: Haiti Study Only one sample’s discordant between Trinity and careStart™ G6PD with 60% cut-off Working Electrode TRINITY G6PD ACTIVITY (UNITS/G Hb) • Specimen : Venous Blood 1. Press the power button and Insert the code chip 2. Insert the test strip into analyser 3. Ready to sample test screen, specimen collection using lancet 4. Specimen Injection & Results display Order Information Product careSTART™ G6PD Biosensor Analyzer careSTART™ G6PD Biosensor Strip careSTART™...

 Open the catalog to page 2
*Prices are pre-tax. They exclude delivery charges and customs duties and do not include additional charges for installation or activation options. Prices are indicative only and may vary by country, with changes to the cost of raw materials and exchange rates.